Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Stem cells from brain transformed to produce insulin at Stanford


With careful coaxing, stem cells from the brain can form insulin-producing cells that mimic those missing in people with diabetes, according to a paper published in the April 26 issue of PLoS Medicine.

Although the work is not yet ready for human patients, Seung Kim, MD, PhD, the lead author and assistant professor of developmental biology at the Stanford University School of Medicine, said it could lead to new ways of transplanting insulin-producing cells into people with diabetes, eventually providing a cure for the disease.

In past work, Kim and members of his lab enticed mouse embryonic stem cells to transform into insulin-producing cells. When transplanted into diabetic mice, these cells effectively made up for the lost insulin-producing cells in the pancreas, called islet cells, and treated the diabetes. However, embryonic stem cells are difficult to work with in the lab and most existing human embryonic stem cell lines are contaminated and can’t be transplanted into humans.

Kim thought that human neural stem cells may be one way to sidestep the more problematic embryonic stem cells. The study shows that his intuition was correct.

"When you look at islets cells you realize that they resemble neurons," Kim said. Like neurons, islet cells respond to external signals by changing their electrical properties and releasing packages of proteins. In the case of islets, that protein is insulin.

What’s more, some neurons in mice and humans take the first steps toward producing insulin. In insects such as fruit flies, the cells that produce insulin and regulate blood sugar are, in fact, neurons. Taken together, this evidence suggested to Kim that neural stem cells may be able to produce insulin.

Despite Kim’s informed hunch, the fact that it worked is a bit surprising.

Until recently, people had though that stem cells taken from the brain would only be able to transform into brain-related tissues such as nerves and support cells. But a group at the Salk Institute in San Diego recently published a report in which neural stem cells transformed into cells that line blood vessels - a far cry from a neuron. "That work gave us confidence that these cells could become more than neuronal cells," Kim said.

Working with the cells in a lab dish, Kim and postdoctoral fellow Yuichi Hori, MD, PhD, now an associate professor at Kobe University in Japan, added a cocktail of chemicals in a sequence that they knew might prod the stem cells to mature into insulin-producing cells. After some trial and error, they found the right combination and sequence. The end result was a dish full of cells that could produce insulin and release it in response to sugar added to the environment.

These cells don’t perfectly mimic human islet cells. Kim’s cells made some, but not all, proteins normally made by islet cells, and they continued to make some proteins found in neurons. Nonetheless, the fact that they could respond to sugar by producing insulin was exciting.

Kim’s next step was to find out if the cells could perform the same feat in a mouse. The group transplanted the cells into a cavity in the kidney where other types of insulin-producing cells have been found to survive. When the blood sugar went up in these mice, the cells once again released insulin. After four weeks the cells had survived, continued to produce insulin and had not changed into other cell types or formed tumors.

Kim noted that the amount of insulin produced wasn’t enough to effectively treat diabetes. Still, the work is a first step towards that eventual goal. It also hints that neuronal stem cells have many potential uses beyond treating brain disease.

He thinks this work has additional value because the method used to produce insulin from neural stem cells is completely new. "The more ways we discover to form insulin-producing cells from stem cells, the more likely it is that stem cells can be used for islet replacement," Kim said.

Kim hopes this work, or related work with other sources of stem cells, could one day replace human islet cells in people with diabetes. Right now, people with diabetes face a lifetime of insulin injections. In rare cases, some patients can receive cell transplants from cadavers, but that source of cells is far smaller than the total number of people who could benefit.

Amy Adams | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Molecular doorstop could be key to new tuberculosis drugs
20.03.2018 | Rockefeller University

nachricht Modified biomaterials self-assemble on temperature cues
20.03.2018 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Earlier flowering of modern winter wheat cultivars

20.03.2018 | Agricultural and Forestry Science

Smithsonian researchers name new ocean zone: The rariphotic

20.03.2018 | Life Sciences

Molecular doorstop could be key to new tuberculosis drugs

20.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>